Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine gum for betel nut cessation in Saipan
NCT05758298Phase 1Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of nicotine in Betel quid dependence (BQD) (3 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Change in average betel nut chews per day at 3 months. Planned start Oct 2023; status: withdrawn.
02
Drugs
nicotine
03
Conditions
Betel quid dependence (BQD)
Beyond the preview
Go deeper on NCT05758298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05758298.